港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

綠竹生物-B

24.800

0.000

成交量：1.16萬

成交額：28.77萬

市值：49.35億

市盈率：-27.25

高：24.800

開：24.800

低：24.800

收：24.800

52周最高：28.000

52周最低：20.000

股本：1.99億

香港流通股本：1.99億

量比：1.12

換手率：0.01%

股息：- -

股息率：- -

每股收益(LYR):-0.910

淨資產收益率：-16.14%

總資產收益率：-8.72%

市淨率：6.12

市盈率(LYR):-27.25

市銷率: - -

資料載入中...

總覽公司新聞公告

綠竹生物-B(02480)：彭玲獲委任為公司副總經理

迫近現金紅線核心品種難挑大樑，綠竹生物-B(02480)何時重返市場聚光燈下？

綠竹生物-B盤中異動快速跳水7.52%報23.120港元

異動解讀 | 綠竹生物-B盤中大漲9.47%，中期業績虧損收窄近三成

異動解讀 | 綠竹生物-B發佈中期業績顯改善，盤中大漲9.47%

綠竹生物-B(02480)發佈中期業績，淨虧損7757萬元，同比收窄29.4%

港股生物醫藥B類股盤初活躍，創勝集團漲超14%，綠竹生物漲近10%

老虎资讯综合

綠竹生物-B(02480)：LZ901頭對頭比較研究的積極臨牀數據

綠竹生物-B盤中異動下午盤股價大漲5.06%

綠竹生物-B盤中異動股價大漲5.79%

綠竹生物-B盤中異動下午盤大幅下跌12.07%報21.500港元

綠竹生物-B盤中異動早盤急速上漲5.96%報24.000港元

綠竹生物-B盤中異動臨近午盤快速拉昇9.00%

綠竹生物-B盤中異動股價大漲5.01%報22.000港元

綠竹生物-B股價重挫10.00% 市值跌4.03億港元

綠竹生物-B(02480)7月17日斥資684.07萬港元回購31.66萬股

綠竹生物-B盤中異動早盤急速下跌7.52%

綠竹生物-B盤中異動股價大漲5.12%報22.600港元

綠竹生物-B盤中異動股價大跌5.38%報21.100港元

綠竹生物-B盤中異動早盤股價大跌10.79%報21.500港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02480/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02480","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02480\",,,,,undefined,":{"symbol":"02480","market":"HK","secType":"STK","nameCN":"綠竹生物-B","latestPrice":24.8,"timestamp":1759216023587,"preClose":24.8,"halted":0,"volume":11600,"delay":0,"floatShares":199000000,"shares":199000000,"eps":-0.9102506742307512,"marketStatus":"國慶日休市","change":0,"latestTime":"09-30 15:07:03","open":24.8,"high":24.8,"low":24.8,"amount":287680,"amplitude":0,"askPrice":24.8,"askSize":8600,"bidPrice":24.68,"bidSize":3400,"shortable":3,"etf":0,"ttmEps":-0.7412742721514062,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1759368600000},"marketStatusCode":7,"adr":0,"listingDate":1683475200000,"exchange":"SEHK","adjPreClose":24.8,"openAndCloseTimeList":[[1759195800000,1759204800000],[1759208400000,1759219200000]],"volumeRatio":1.1153845982248525,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02480\",,,,,undefined,":{"symbol":"02480","floatShares":199000000,"roa":"-8.72%","roe":"-16.14%","lyrEps":-0.910244,"volumeRatio":1.1153845982248525,"shares":199000000,"dividePrice":0,"high":24.8,"amplitude":0,"preClose":24.8,"low":24.8,"week52Low":20,"pbRate":"6.12","week52High":28,"institutionHeld":0,"latestPrice":24.8,"committee":-0.433333,"eps":-0.9102435907332901,"divideRate":0,"volume":11600,"delay":0,"ttmEps":-0.7412685036147015,"open":24.8,"prevYearClose":22.95,"prevWeekClose":25.2,"prevMonthClose":24.8,"prevQuarterClose":24.8,"fiveDayClose":24.84,"twentyDayClose":24.04,"sixtyDayClose":22.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02480\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"02480","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-18","symbol":"02480","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742261400000,"name":null,"time":"盤後","dateTimestamp":1742227200000,"actualEps":null},{"date":"2024-08-21","symbol":"02480","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724203800000,"name":null,"time":"盤後","dateTimestamp":1724169600000,"actualEps":null},{"date":"2024-03-15","symbol":"02480","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710466200000,"name":null,"time":"","dateTimestamp":1710432000000,"actualEps":null},{"date":"2023-08-21","symbol":"02480","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692581400000,"name":null,"time":"","dateTimestamp":1692547200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02480\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02480\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1745251200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02480\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02480","date":"2025-09-29","current":-33.455903,"percent":0.223906,"low":-50.634384,"twenty":-33.571263,"median":-22.242053,"eighty":-14.297233,"high":-4.114514,"avg":-23.13716,"sd":10.614986,"marketCap":4933048153},"quantilePoints":[{"date":"2023-05-12","current":-5.074703,"twenty":-5.141932,"median":-4.426132,"eighty":-4.315282,"marketCap":4150205156},{"date":"2023-05-19","current":-6.276926,"twenty":-6.157049,"median":-5.438944,"eighty":-4.414,"marketCap":5061225800},{"date":"2023-05-25","current":-6.025537,"twenty":-6.282911,"median":-5.817621,"eighty":-4.815275,"marketCap":4838531864},{"date":"2023-06-02","current":-7.108523,"twenty":-6.788873,"median":-6.18905,"eighty":-5.276391,"marketCap":5688817799},{"date":"2023-06-09","current":-8.132145,"twenty":-7.304397,"median":-6.309111,"eighty":-5.444563,"marketCap":6498613927},{"date":"2023-06-16","current":-8.09491,"twenty":-8.243136,"median":-6.773271,"eighty":-5.552638,"marketCap":6437879217},{"date":"2023-06-23","current":-7.99853,"twenty":-8.19132,"median":-7.057928,"eighty":-5.776037,"marketCap":6326532250},{"date":"2023-06-30","current":-10.22826,"twenty":-8.355382,"median":-7.314546,"eighty":-6.074942,"marketCap":8016981667},{"date":"2023-07-07","current":-8.773125,"twenty":-8.461217,"median":-7.999898,"eighty":-6.165049,"marketCap":6863022184},{"date":"2023-07-14","current":-8.064731,"twenty":-8.488591,"median":-8.098962,"eighty":-6.2242,"marketCap":6397389411},{"date":"2023-07-21","current":-8.217769,"twenty":-8.461217,"median":-8.132145,"eighty":-6.282911,"marketCap":6488491475},{"date":"2023-07-28","current":-8.419084,"twenty":-8.421723,"median":-8.150258,"eighty":-6.305666,"marketCap":6640328249},{"date":"2023-08-04","current":-8.302611,"twenty":-8.433084,"median":-8.175239,"eighty":-6.384674,"marketCap":6559348636},{"date":"2023-08-11","current":-8.233788,"twenty":-8.421723,"median":-8.173568,"eighty":-6.59262,"marketCap":6468246572},{"date":"2023-08-18","current":-8.371035,"twenty":-8.447732,"median":-8.198547,"eighty":-6.788873,"marketCap":6528981282},{"date":"2023-08-25","current":-36.775961,"twenty":-8.488591,"median":-8.22448,"eighty":-6.910536,"marketCap":6032981153},{"date":"2023-09-01","current":-50.634384,"twenty":-8.532708,"median":-8.24341,"eighty":-7.078166,"marketCap":8340900118},{"date":"2023-09-08","current":-38.241641,"twenty":-8.777665,"median":-8.259865,"eighty":-7.170634,"marketCap":6225307734},{"date":"2023-09-15","current":-42.575145,"twenty":-36.451658,"median":-8.302611,"eighty":-7.304397,"marketCap":6984491604},{"date":"2023-09-22","current":-47.100298,"twenty":-37.976001,"median":-8.354776,"eighty":-7.575971,"marketCap":7693063216},{"date":"2023-09-29","current":-43.864392,"twenty":-38.642311,"median":-8.372129,"eighty":-7.934606,"marketCap":7176818184},{"date":"2023-10-06","current":-42.833147,"twenty":-39.549549,"median":-8.411287,"eighty":-7.998804,"marketCap":7004736507},{"date":"2023-10-13","current":-42.773246,"twenty":-40.772579,"median":-8.427902,"eighty":-8.012865,"marketCap":6984491604},{"date":"2023-10-20","current":-41.038761,"twenty":-42.472898,"median":-8.45323,"eighty":-8.070767,"marketCap":6690940507},{"date":"2023-10-27","current":-43.478764,"twenty":-42.528314,"median":-8.467479,"eighty":-8.09491,"marketCap":7085716120},{"date":"2023-11-03","current":-43.115829,"twenty":-42.671946,"median":-8.490236,"eighty":-8.096666,"marketCap":7045226313},{"date":"2023-11-10","current":-40.274636,"twenty":-42.575145,"median":-8.527418,"eighty":-8.103013,"marketCap":6579593540},{"date":"2023-11-17","current":-41.142791,"twenty":-42.528314,"median":-8.744908,"eighty":-8.132145,"marketCap":6782042572},{"date":"2023-11-24","current":-41.415901,"twenty":-42.502629,"median":-8.780691,"eighty":-8.13418,"marketCap":6883267088},{"date":"2023-12-01","current":-40.638335,"twenty":-42.482551,"median":-23.319225,"eighty":-8.138547,"marketCap":6782042572},{"date":"2023-12-08","current":-36.540226,"twenty":-42.364281,"median":-36.540226,"eighty":-8.16086,"marketCap":6073470960},{"date":"2023-12-15","current":-31.365274,"twenty":-42.353974,"median":-36.444746,"eighty":-8.166335,"marketCap":5243429928},{"date":"2023-12-22","current":-36.354714,"twenty":-42.222786,"median":-35.228598,"eighty":-8.171278,"marketCap":6073470960},{"date":"2023-12-29","current":-36.041365,"twenty":-42.205507,"median":-36.198039,"eighty":-8.171649,"marketCap":6053226056},{"date":"2024-01-05","current":-37.632709,"twenty":-42.186199,"median":-36.19804,"eighty":-8.173234,"marketCap":6275919992},{"date":"2024-01-12","current":-35.792717,"twenty":-42.165268,"median":-36.401933,"eighty":-8.177335,"marketCap":5972246444},{"date":"2024-01-19","current":-34.566218,"twenty":-41.985044,"median":-36.261145,"eighty":-8.187707,"marketCap":5759674960},{"date":"2024-01-26","current":-34.945217,"twenty":-41.702629,"median":-35.889121,"eighty":-8.200201,"marketCap":5800164766},{"date":"2024-02-02","current":-34.134928,"twenty":-41.702629,"median":-35.510658,"eighty":-8.208717,"marketCap":5658450444},{"date":"2024-02-09","current":-34.696826,"twenty":-41.629046,"median":-35.173968,"eighty":-8.223137,"marketCap":5779919863},{"date":"2024-02-16","current":-34.021056,"twenty":-41.592669,"median":-35.129341,"eighty":-8.23119,"marketCap":5668572896},{"date":"2024-02-23","current":-29.437593,"twenty":-41.560591,"median":-34.945217,"eighty":-8.233788,"marketCap":4879021671},{"date":"2024-03-01","current":-26.855742,"twenty":-41.552583,"median":-34.827443,"eighty":-8.24341,"marketCap":4453878704},{"date":"2024-03-08","current":-23.915389,"twenty":-41.5498,"median":-34.696826,"eighty":-8.246673,"marketCap":3968001027},{"date":"2024-03-15","current":-22.959574,"twenty":-41.415901,"median":-34.547961,"eighty":-8.257826,"marketCap":3806041801},{"date":"2024-03-22","current":-13.452398,"twenty":-41.280844,"median":-34.159277,"eighty":-8.261904,"marketCap":3644082576},{"date":"2024-03-28","current":-13.495561,"twenty":-41.170402,"median":-34.134928,"eighty":-8.27397,"marketCap":3644082576},{"date":"2024-04-05","current":-14.119656,"twenty":-41.102561,"median":-34.049221,"eighty":-8.287236,"marketCap":3810090782},{"date":"2024-04-12","current":-14.54654,"twenty":-41.040833,"median":-33.902332,"eighty":-8.321936,"marketCap":3927511220},{"date":"2024-04-19","current":-15.384478,"twenty":-40.998673,"median":-33.006233,"eighty":-8.351253,"marketCap":4150205156},{"date":"2024-04-26","current":-21.264303,"twenty":-40.932898,"median":-32.88325,"eighty":-8.354171,"marketCap":5729307605},{"date":"2024-05-03","current":-25.197419,"twenty":-40.921141,"median":-31.75475,"eighty":-8.360451,"marketCap":5466123864},{"date":"2024-05-10","current":-24.951534,"twenty":-40.901135,"median":-31.289029,"eighty":-8.371254,"marketCap":5425634057},{"date":"2024-05-17","current":-23.216659,"twenty":-40.873797,"median":-30.477756,"eighty":-8.372129,"marketCap":5040980896},{"date":"2024-05-24","current":-22.335273,"twenty":-40.869522,"median":-29.437593,"eighty":-8.398215,"marketCap":4838531864},{"date":"2024-05-31","current":-18.671602,"twenty":-40.638335,"median":-26.493199,"eighty":-8.411287,"marketCap":4048980640},{"date":"2024-06-07","current":-18.489144,"twenty":-40.367709,"median":-25.801624,"eighty":-8.419084,"marketCap":4004441852},{"date":"2024-06-14","current":-18.89905,"twenty":-40.350491,"median":-25.653838,"eighty":-8.422603,"marketCap":4089470446},{"date":"2024-06-21","current":-21.188839,"twenty":-40.288946,"median":-25.229843,"eighty":-8.430554,"marketCap":4575348123},{"date":"2024-06-28","current":-20.587968,"twenty":-40.108586,"median":-24.951534,"eighty":-8.438052,"marketCap":4443756252},{"date":"2024-07-05","current":-20.873885,"twenty":-40.009541,"median":-23.915389,"eighty":-8.447732,"marketCap":4504490962},{"date":"2024-07-12","current":-22.529465,"twenty":-39.85132,"median":-23.456349,"eighty":-8.458254,"marketCap":4868899219},{"date":"2024-07-19","current":-22.508759,"twenty":-39.66272,"median":-23.163847,"eighty":-8.465129,"marketCap":4864515374},{"date":"2024-07-26","current":-21.823109,"twenty":-39.542312,"median":-22.952784,"eighty":-8.478815,"marketCap":4733856903},{"date":"2024-08-02","current":-21.186785,"twenty":-39.436158,"median":-22.899165,"eighty":-8.488591,"marketCap":4593147781},{"date":"2024-08-09","current":-20.539925,"twenty":-39.267163,"median":-22.755777,"eighty":-8.490269,"marketCap":4482590613},{"date":"2024-08-16","current":-20.900232,"twenty":-38.975641,"median":-22.694782,"eighty":-8.502601,"marketCap":4562995826},{"date":"2024-08-23","current":-15.034988,"twenty":-38.826209,"median":-22.519112,"eighty":-8.520744,"marketCap":4593147781},{"date":"2024-08-30","current":-14.248445,"twenty":-38.553098,"median":-22.372848,"eighty":-8.532708,"marketCap":4382084097},{"date":"2024-09-06","current":-14.045602,"twenty":-38.373279,"median":-22.224227,"eighty":-8.647314,"marketCap":4321780188},{"date":"2024-09-13","current":-14.377214,"twenty":-38.293924,"median":-21.962109,"eighty":-8.749616,"marketCap":4412236052},{"date":"2024-09-20","current":-13.933408,"twenty":-38.214918,"median":-21.716284,"eighty":-8.770319,"marketCap":4301678884},{"date":"2024-09-27","current":-15.500476,"twenty":-38.019583,"median":-21.523409,"eighty":-8.776151,"marketCap":4814262116},{"date":"2024-10-04","current":-15.018573,"twenty":-37.764917,"median":-21.40631,"eighty":-8.824208,"marketCap":4643401039},{"date":"2024-10-10","current":-16.1962,"twenty":-37.677753,"median":-21.326372,"eighty":-8.998274,"marketCap":4975072542},{"date":"2024-10-18","current":-17.234936,"twenty":-37.667079,"median":-21.233145,"eighty":-10.22826,"marketCap":5266541438},{"date":"2024-10-25","current":-15.755835,"twenty":-37.632709,"median":-21.13539,"eighty":-13.11092,"marketCap":4814262116},{"date":"2024-11-01","current":-16.106802,"twenty":-37.40391,"median":-21.038608,"eighty":-13.302926,"marketCap":4924819284},{"date":"2024-11-08","current":-14.308698,"twenty":-37.309147,"median":-20.990417,"eighty":-13.452398,"marketCap":4341881491},{"date":"2024-11-15","current":-14.150671,"twenty":-37.266259,"median":-20.950887,"eighty":-13.495561,"marketCap":4261476278},{"date":"2024-11-22","current":-13.925064,"twenty":-37.125428,"median":-20.910512,"eighty":-13.515744,"marketCap":4191121717},{"date":"2024-11-29","current":-14.868539,"twenty":-37.119062,"median":-20.873885,"eighty":-13.591232,"marketCap":4472539962},{"date":"2024-12-06","current":-14.903644,"twenty":-37.083223,"median":-20.741791,"eighty":-13.638824,"marketCap":4472539962},{"date":"2024-12-13","current":-17.196727,"twenty":-37.024117,"median":-20.632031,"eighty":-13.7104,"marketCap":5155984270},{"date":"2024-12-20","current":-15.705551,"twenty":-36.775961,"median":-20.444203,"eighty":-13.755213,"marketCap":4683044445},{"date":"2024-12-27","current":-14.975706,"twenty":-36.759538,"median":-20.147116,"eighty":-13.762915,"marketCap":4461956510},{"date":"2025-01-03","current":-14.961058,"twenty":-36.698715,"median":-19.723631,"eighty":-13.769631,"marketCap":4461956510},{"date":"2025-01-10","current":-13.529695,"twenty":-36.590433,"median":-19.407269,"eighty":-13.769631,"marketCap":4019780640},{"date":"2025-01-17","current":-15.445213,"twenty":-36.515856,"median":-18.99261,"eighty":-13.802468,"marketCap":4592599381},{"date":"2025-01-24","current":-15.416209,"twenty":-36.451658,"median":-18.88953,"eighty":-13.864251,"marketCap":4612698284},{"date":"2025-01-28","current":-16.178623,"twenty":-36.424013,"median":-18.775806,"eighty":-13.880338,"marketCap":4863934574},{"date":"2025-02-07","current":-16.263139,"twenty":-36.403585,"median":-18.459002,"eighty":-13.90509,"marketCap":4863934574},{"date":"2025-02-14","current":-14.752701,"twenty":-36.366396,"median":-18.399312,"eighty":-13.910841,"marketCap":4401659800},{"date":"2025-02-21","current":-15.040713,"twenty":-36.355274,"median":-18.348745,"eighty":-13.922298,"marketCap":4512203768},{"date":"2025-02-28","current":-13.981349,"twenty":-36.205004,"median":-18.003871,"eighty":-13.922298,"marketCap":4180571865},{"date":"2025-03-07","current":-14.862727,"twenty":-36.066607,"median":-17.630273,"eighty":-13.931739,"marketCap":4461956510},{"date":"2025-03-14","current":-16.664293,"twenty":-35.91957,"median":-17.25119,"eighty":-13.952205,"marketCap":5004626896},{"date":"2025-03-21","current":-27.850982,"twenty":-35.811998,"median":-17.265054,"eighty":-13.961209,"marketCap":5024725800},{"date":"2025-03-28","current":-27.851641,"twenty":-35.341422,"median":-17.666035,"eighty":-13.977536,"marketCap":5014676348},{"date":"2025-04-03","current":-27.730368,"twenty":-35.205527,"median":-18.003871,"eighty":-13.985669,"marketCap":4994577445},{"date":"2025-04-11","current":-27.811891,"twenty":-35.180439,"median":-18.348745,"eighty":-13.99053,"marketCap":4964429090},{"date":"2025-04-17","current":-27.831311,"twenty":-35.17174,"median":-18.396379,"eighty":-13.991851,"marketCap":4974478542},{"date":"2025-04-25","current":-27.496924,"twenty":-35.152775,"median":-18.437994,"eighty":-13.995129,"marketCap":4924231284},{"date":"2025-05-02","current":-24.638746,"twenty":-35.090285,"median":-18.489144,"eighty":-14.008243,"marketCap":4421758704},{"date":"2025-05-09","current":-23.799704,"twenty":-35.025533,"median":-18.880009,"eighty":-14.027432,"marketCap":4301165284},{"date":"2025-05-16","current":-23.16559,"twenty":-34.958043,"median":-18.974865,"eighty":-14.042927,"marketCap":4220769672},{"date":"2025-05-23","current":-22.216636,"twenty":-34.940734,"median":-19.278428,"eighty":-14.045602,"marketCap":4059978446},{"date":"2025-05-30","current":-24.090424,"twenty":-34.902751,"median":-19.655266,"eighty":-14.04584,"marketCap":4421758704},{"date":"2025-06-06","current":-25.776691,"twenty":-34.787786,"median":-20.147116,"eighty":-14.058641,"marketCap":4743341155},{"date":"2025-06-13","current":-25.002243,"twenty":-34.74329,"median":-20.563947,"eighty":-14.06475,"marketCap":4602648832},{"date":"2025-06-20","current":-27.239235,"twenty":-34.705216,"median":-20.639904,"eighty":-14.081075,"marketCap":5004626896},{"date":"2025-06-27","current":-26.181367,"twenty":-34.611032,"median":-20.808443,"eighty":-14.089888,"marketCap":4823736768},{"date":"2025-07-04","current":-26.289221,"twenty":-34.575564,"median":-20.875906,"eighty":-14.10824,"marketCap":4843835671},{"date":"2025-07-11","current":-23.476688,"twenty":-34.544309,"median":-20.920792,"eighty":-14.128661,"marketCap":4321264188},{"date":"2025-07-18","current":-24.372684,"twenty":-34.520405,"median":-20.954278,"eighty":-14.144268,"marketCap":4482671220},{"date":"2025-07-25","current":-23.906615,"twenty":-34.301249,"median":-21.010044,"eighty":-14.158178,"marketCap":4412940778},{"date":"2025-08-01","current":-25.480816,"twenty":-34.15039,"median":-21.04444,"eighty":-14.165177,"marketCap":4674460952},{"date":"2025-08-08","current":-25.200919,"twenty":-34.138743,"median":-21.186785,"eighty":-14.186449,"marketCap":4634678305},{"date":"2025-08-15","current":-25.455378,"twenty":-34.100402,"median":-21.248724,"eighty":-14.20102,"marketCap":4674460952},{"date":"2025-08-22","current":-27.143644,"twenty":-34.043588,"median":-21.382765,"eighty":-14.203723,"marketCap":4968852535},{"date":"2025-08-29","current":-32.995171,"twenty":-33.985902,"median":-21.461832,"eighty":-14.222173,"marketCap":4901222036},{"date":"2025-09-05","current":-32.223651,"twenty":-33.926386,"median":-21.576779,"eighty":-14.242527,"marketCap":4781874097},{"date":"2025-09-12","current":-33.450238,"twenty":-33.839238,"median":-21.892609,"eighty":-14.268053,"marketCap":4972830800},{"date":"2025-09-19","current":-33.313317,"twenty":-33.627741,"median":-22.153182,"eighty":-14.282987,"marketCap":4948961212},{"date":"2025-09-26","current":-33.829558,"twenty":-33.627741,"median":-22.229344,"eighty":-14.293982,"marketCap":5012613446},{"date":"2025-09-29","current":-33.216429,"twenty":-33.571263,"median":-22.242053,"eighty":-14.297233,"marketCap":4933048153}],"updateTime":1759262410385},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02480\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2570202067","title":"綠竹生物-B(02480)：彭玲獲委任為公司副總經理","url":"https://stock-news.laohu8.com/highlight/detail?id=2570202067","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570202067?lang=zh_tw&edition=fundamental","pubTime":"2025-09-25 17:15","pubTimestamp":1758791725,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿竹生物-B(02480)发布公告，公司执行董事、副董事长彭玲女士已获委任为公司副总经理。作为公司副总经理，彭玲女士将主要负责集团各项目的质量研究、质量控制及质量保证工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2566632589","title":"迫近現金紅線核心品種難挑大樑，綠竹生物-B(02480)何時重返市場聚光燈下？","url":"https://stock-news.laohu8.com/highlight/detail?id=2566632589","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566632589?lang=zh_tw&edition=fundamental","pubTime":"2025-09-11 17:06","pubTimestamp":1757581609,"startTime":"0","endTime":"0","summary":"8月18日和19日，绿竹生物连续2个交易日收涨逾8%，期间最高股价触及28港元，创下公司股价近15个月以来的新高。即使此次公司核心品种披露重大利好，绿竹生物在8月19日的单日成交量仅为69600股，但这也是其8月至今的最高单日成交量。从成交量来看，绿竹生物依旧处在被市场遗忘的边缘。财报显示，绿竹生物当期现金及现金等价物合计9921.9万元，同比减少29.20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1344132.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2565025556","title":"綠竹生物-B盤中異動 快速跳水7.52%報23.120港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565025556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565025556?lang=zh_tw&edition=fundamental","pubTime":"2025-09-05 15:00","pubTimestamp":1757055600,"startTime":"0","endTime":"0","summary":"2025年09月05日下午盘15时00分，绿竹生物-B股票出现异动，股价大幅下挫7.52%。截至发稿，该股报23.120港元/股，成交量1.32万股，换手率0.01%，振幅7.60%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为5.89%。其相关个股中，宜明昂科-B、欧康维视生物-B、康诺亚-B涨幅较大，振幅较大的相关个股有欧康维视生物-B、宜明昂科-B、君实生物，振幅分别为16.20%、14.72%、13.82%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905150000a4b596ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905150000a4b596ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"1100387642","title":"異動解讀 | 綠竹生物-B盤中大漲9.47%，中期業績虧損收窄近三成","url":"https://stock-news.laohu8.com/highlight/detail?id=1100387642","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100387642?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 16:40","pubTimestamp":1756197623,"startTime":"0","endTime":"0","summary":"绿竹生物-B今日盘中大涨9.47%，引起市场广泛关注。该股价的显著上涨与公司最新发布的中期业绩报告密切相关。根据绿竹生物-B发布的截至2025年6月30日止六个月业绩报告，公司净亏损为7757万元人民币，同比收窄29.4%。尽管公司仍处于亏损状态，但亏损幅度的显著收窄被投资者视为积极信号。分析人士指出，尽管绿竹生物-B的收入有所下降，但净亏损的大幅收窄表明公司在成本控制和运营效率方面可能取得了进展。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02480"],"gpt_icon":0},{"id":"1131486512","title":"異動解讀 | 綠竹生物-B發佈中期業績顯改善，盤中大漲9.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131486512","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131486512?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 16:40","pubTimestamp":1756197622,"startTime":"0","endTime":"0","summary":"今日盘中，绿竹生物-B（02480.HK）股价大涨9.47%，引起市场广泛关注。\n\n消息面上，绿竹生物-B于今日发布了截至2025年6月30日止的中期业绩报告。报告显示，公司期内其他收入为485万元人民币，同比下降50.2%；净亏损为7757万元人民币，同比收窄29.4%；每股基本亏损0.39元人民币。\n\n尽管公司仍处于亏损状态，但净亏损同比大幅收窄近30%，这表明公司的经营状况正在逐步改善。投资者可能对绿竹生物-B的未来发展前景持乐观态度，推动了股价的上涨。然而，投资者仍需密切关注公司后续的经营表现和行业发展动向。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02480"],"gpt_icon":0},{"id":"2562778683","title":"綠竹生物-B(02480)發佈中期業績，淨虧損7757萬元，同比收窄29.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562778683","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562778683?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 16:35","pubTimestamp":1756197322,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿竹生物-B 发布截至2025年6月30日止六个月业绩，其他收入485万元，同比下降50.2%;净亏损7757万元，同比收窄29.4%;每股基本亏损0.39元。于2025年上半年，公司已实现多项公司重大里程碑。2025年1月，集团就其核心产品LZ901向国家药监局提交生物制品许可申请，随后于2025年2月获受理。此外，于2025年上半年，集团亦成功完成了LZ901头对头比较研究。董事会相信，该等正面成果为LZ901未来的商业化奠定坚实的基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1335247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"1116360898","title":"港股生物醫藥B類股盤初活躍，創勝集團漲超14%，綠竹生物漲近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116360898","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116360898?lang=zh_tw&edition=fundamental","pubTime":"2025-08-19 09:48","pubTimestamp":1755568113,"startTime":"0","endTime":"0","summary":"8月19日（周二），港股$生物(000504)$医药B类股盘初活跃，创胜集团涨超14%，绿竹生物涨近10%，$启明医疗(02500)$、$科伦博泰(06990)$生物涨超6%，$来凯医药(02105)$、和誉涨超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3c69330474cfca501aba698b1d21b7cf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","06628","02480","02500","BK4614","07226","BK1161"],"gpt_icon":0},{"id":"2560978987","title":"綠竹生物-B(02480)：LZ901頭對頭比較研究的積極臨牀數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2560978987","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560978987?lang=zh_tw&edition=fundamental","pubTime":"2025-08-18 07:52","pubTimestamp":1755474729,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿竹生物-B 发布公告，集团核心产品LZ901与重组糖蛋白E亚单位疫苗HZ/su疫苗进行头对头比较的一项随机、主动对照及非劣效性试验，在50岁及以上成人中获得了积极的免疫原性和安全性数据。该研究招募了301名50岁或以上健康成人，其中至少291名健康成人接种了两剂 LZ901或HZ/su疫苗。截至本公告日期，LZ901的生物制品许可申请已获中华人民共和国国家药品监督管理局受理，目前正在评审中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2aff25c238125730bc7536591e12b53f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"绿竹生物-B(02480)：LZ901头对头比较研究的积极临床数据","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2558639360","title":"綠竹生物-B盤中異動 下午盤股價大漲5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558639360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558639360?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 13:13","pubTimestamp":1754889188,"startTime":"0","endTime":"0","summary":"2025年08月11日下午盘13时13分，绿竹生物-B股票出现波动，股价大幅上涨5.06%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，中慧生物-B、北海康成-B、三叶草生物-B涨幅较大，振幅较大的相关个股有北海康成-B、三叶草生物-B、中生北控生物科技，振幅分别为36.30%、28.57%、16.47%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113130994dc0f82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081113130994dc0f82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2557418073","title":"綠竹生物-B盤中異動 股價大漲5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557418073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557418073?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 10:26","pubTimestamp":1754447163,"startTime":"0","endTime":"0","summary":"2025年08月06日早盘10时26分，绿竹生物-B股票出现波动，股价快速拉升5.79%。绿竹生物-B股票所在的生物技术行业中，整体跌幅为0.85%。绿竹生物-B公司简介：北京绿竹生物技术股份有限公司是一家主要从事药物发现、研究及开发及商业化的中国公司。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080610260397368562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080610260397368562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2555001415","title":"綠竹生物-B盤中異動 下午盤大幅下跌12.07%報21.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555001415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555001415?lang=zh_tw&edition=fundamental","pubTime":"2025-07-31 15:09","pubTimestamp":1753945746,"startTime":"0","endTime":"0","summary":"2025年07月31日下午盘15时09分，绿竹生物-B股票出现波动，股价急速下挫12.07%。截至发稿，该股报21.500港元/股，成交量2400股，换手率0.00%，振幅13.91%。绿竹生物-B股票所在的生物技术行业中，整体跌幅为1.42%。其相关个股中，创胜集团-B、科伦博泰生物-B、锦欣生殖涨幅较大，振幅较大的相关个股有奥星生命科技、中国抗体-B、创胜集团-B，振幅分别为22.50%、19.32%、14.16%。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073115090697297d86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073115090697297d86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2555066083","title":"綠竹生物-B盤中異動 早盤急速上漲5.96%報24.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555066083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555066083?lang=zh_tw&edition=fundamental","pubTime":"2025-07-29 09:57","pubTimestamp":1753754248,"startTime":"0","endTime":"0","summary":"2025年07月29日早盘09时57分，绿竹生物-B股票出现异动，股价大幅拉升5.96%。截至发稿，该股报24.000港元/股，成交量1600股，换手率0.00%，振幅4.42%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为1.22%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095728a468a035&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095728a468a035&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2553278453","title":"綠竹生物-B盤中異動 臨近午盤快速拉昇9.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553278453","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553278453?lang=zh_tw&edition=fundamental","pubTime":"2025-07-24 11:59","pubTimestamp":1753329590,"startTime":"0","endTime":"0","summary":"2025年07月24日临近午盘11时59分，绿竹生物-B股票出现波动，股价急速拉升9.00%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为0.96%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072411595094b76bc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072411595094b76bc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2553293827","title":"綠竹生物-B盤中異動 股價大漲5.01%報22.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553293827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553293827?lang=zh_tw&edition=fundamental","pubTime":"2025-07-23 10:56","pubTimestamp":1753239379,"startTime":"0","endTime":"0","summary":"2025年07月23日早盘10时56分，绿竹生物-B股票出现波动，股价大幅拉升5.01%。截至发稿，该股报22.000港元/股，成交量800股，换手率0.00%，振幅2.39%。资金方面，该股资金流入1.3万港元，流出4300港元。绿竹生物-B股票所在的生物技术行业中，整体涨幅为0.99%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723105619954defe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723105619954defe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2553744755","title":"綠竹生物-B股價重挫10.00% 市值跌4.03億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553744755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553744755?lang=zh_tw&edition=fundamental","pubTime":"2025-07-21 09:40","pubTimestamp":1753062016,"startTime":"0","endTime":"0","summary":"2025年07月21日早盘09时40分，绿竹生物-B股票出现异动，股价快速下跌10.00%。截至发稿，该股报20.250港元/股，成交量1400股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出2.025万港元。绿竹生物-B股票所在的生物技术行业中，整体跌幅为0.48%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721094016a6b67f25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721094016a6b67f25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2552748365","title":"綠竹生物-B(02480)7月17日斥資684.07萬港元回購31.66萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2552748365","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552748365?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 18:37","pubTimestamp":1752748627,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿竹生物-B(02480)发布公告，于2025年7月17日，该公司斥资684.07万港元回购31.66万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1319063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2552337694","title":"綠竹生物-B盤中異動 早盤急速下跌7.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552337694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552337694?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 11:24","pubTimestamp":1752722690,"startTime":"0","endTime":"0","summary":"2025年07月17日早盘11时24分，绿竹生物-B股票出现波动，股价急速下挫7.52%。截至发稿，该股报20.900港元/股，成交量7600股，换手率0.00%，振幅7.52%。绿竹生物-B股票所在的生物技术行业中，整体涨幅为4.92%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071711245097a93634&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071711245097a93634&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2551549951","title":"綠竹生物-B盤中異動 股價大漲5.12%報22.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551549951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551549951?lang=zh_tw&edition=fundamental","pubTime":"2025-07-15 15:57","pubTimestamp":1752566235,"startTime":"0","endTime":"0","summary":"2025年07月15日临近收盘15时57分，绿竹生物-B股票出现异动，股价快速上涨5.12%。截至发稿，该股报22.600港元/股，成交量800股，换手率0.00%，振幅1.40%。资金方面，该股资金流入9010港元，流出4460港元。绿竹生物-B股票所在的生物技术行业中，整体涨幅为3.24%。该公司还从事对外授权人类疫苗及治疗性生物制剂。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715155715a44bbf31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715155715a44bbf31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02480"],"gpt_icon":0},{"id":"2550147604","title":"綠竹生物-B盤中異動 股價大跌5.38%報21.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550147604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550147604?lang=zh_tw&edition=fundamental","pubTime":"2025-07-11 11:21","pubTimestamp":1752204090,"startTime":"0","endTime":"0","summary":"2025年07月11日早盘11时21分，绿竹生物-B股票出现波动，股价大幅下跌5.38%。截至发稿，该股报21.100港元/股，成交量4800股，换手率0.00%，振幅5.61%。资金方面，该股资金流入0港元，流出2.611万港元。绿竹生物-B股票所在的生物技术行业中，整体涨幅为2.66%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071111213097a1c1b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071111213097a1c1b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0},{"id":"2549306209","title":"綠竹生物-B盤中異動 早盤股價大跌10.79%報21.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549306209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549306209?lang=zh_tw&edition=fundamental","pubTime":"2025-07-07 11:13","pubTimestamp":1751858022,"startTime":"0","endTime":"0","summary":"2025年07月07日早盘11时13分，绿竹生物-B股票出现波动，股价快速下挫10.79%。截至发稿，该股报21.500港元/股，成交量3600股，换手率0.00%，振幅9.13%。资金方面，该股资金流入0港元，流出7.958万港元。绿竹生物-B股票所在的生物技术行业中，整体跌幅为1.74%。其临床阶段在研产品包括重组带状疱疹疫苗LZ901,以及抗体注射产品K3和K193。其LZ901主要应用于预防年龄为50岁及以上成人水痘带状疱疹病毒引起的带状疱疹。该公司在中国国内市场和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707111342a69a0bef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707111342a69a0bef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02480","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":45,"code":"91000000","status":"200"}]}}